Table 4 Predicted and actual risk of COVID-19 deterioration, as well as the actual risk of using an MV and ECMO in the original cohort according to each (a) DOATS score and (b) DOAT score
(a) | (b) | ||||||||
|---|---|---|---|---|---|---|---|---|---|
DOATS score | No. | Predicted risk (%) | Actual risk (%) | Actual risk of MV/ECMO (%) | DOAT score | No. | Predicted risk (%) | Actual risk (%) | Actual risk of MV/ECMO (%) |
-2 | 95 | 0.8 | 1 | 0 | -2 | 126 | 0.9 | 0.8 | 0 |
-1 | 31 | 1 | 0 | 0 | -1 | 42 | 1.2 | 0 | 0 |
0 | 125 | 1.3 | 0.8 | 0 | 0 | 194 | 1.7 | 1 | 0 |
1 | 62 | 1.7 | 3.2 | 0 | 1 | 214 | 2.5 | 3.7 | 0 |
2 | 96 | 2.2 | 4.2 | 0 | 2 | 56 | 3.5 | 8.9 | 0 |
3 | 186 | 2.9 | 3.8 | 0 | 3 | 180 | 5 | 2.8 | 0 |
4 | 74 | 3.7 | 1.4 | 0 | 4 | 271 | 6.9 | 7.8 | 0 |
5 | 145 | 4.8 | 3.5 | 0 | 5 | 109 | 9.6 | 10.1 | 0 |
6 | 151 | 6.2 | 2 | 0 | 6 | 53 | 13.3 | 15.1 | 0 |
7 | 46 | 8 | 6.5 | 2.2 | 7 | 59 | 18 | 22 | 3.4 |
8 | 130 | 10.2 | 13.9 | 0 | 8 | 75 | 23.9 | 26.7 | 0 |
9 | 108 | 12.9 | 15.7 | 0 | 9 | 90 | 31 | 32.2 | 0 |
10 | 19 | 16.2 | 31.6 | 0 | 11 | 13 | 47.9 | 46.2 | 15.4 |
11 | 65 | 20.2 | 20 | 0 | 12 | 23 | 56.9 | 43.5 | 13 |
12 | 54 | 24.9 | 25.9 | 1.9 | Â | Â | Â | Â | Â |
13 | 10 | 30.2 | 40 | 10 | Â | Â | Â | Â | Â |
14 | 58 | 36.2 | 32.8 | 0 | Â | Â | Â | Â | Â |
15 | 17 | 42.6 | 47.1 | 5.9 | Â | Â | Â | Â | Â |
16 | 8 | 49.2 | 37.5 | 0 | Â | Â | Â | Â | Â |
17 | 12 | 55.9 | 41.7 | 8.3 | Â | Â | Â | Â | Â |
18 | 4 | 62.3 | 75 | 25 | Â | Â | Â | Â | Â |
19 | 5 | 68.4 | 40 | 20 | Â | Â | Â | Â | Â |